Subscribe To

Price Alert Latest News Economic Calendar News

KIDS / OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 2, 2023

WARSAW, Ind., April 17, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2023 financial results on Monday, May 1, 2023, after the market closes. OrthoPediatrics will host a conference call on Tuesday, May 2, 2023, at 8:00 a.m. ET to discuss the results. Read More

Demo Live Account See Partner Details

Content Topics

Orthopediatrics

Corp

Report

First

Quarter

2022

Financial

Results

Stock

KIDS

Posted: Apr 17 2023, 08:05

Author Name: GlobeNewsWire

KIDS News

By GlobeNewsWire
October 17, 2023

OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023

WARSAW, Ind., Oct. 17, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused

By Zacks Investment Research
October 17, 2023

Strength Seen in OrthoPediatrics (KIDS): Can Its 8.1% Jump Turn into More Strength?

OrthoPediatrics (KIDS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not h

By Seeking Alpha
August 1, 2023

OrthoPediatrics Corp. (KIDS) Q2 2023 Earnings Call Transcript

OrthoPediatrics Corp. (NASDAQ:KIDS ) Q2 2023 Earnings Conference Call August 1, 2023 8:00 AM ET Company Participants Trip Taylor - Investor Relations,

By Zacks Investment Research
July 31, 2023

Compared to Estimates, OrthoPediatrics (KIDS) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended June 2023, it could

By Zacks Investment Research
July 31, 2023

OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.19 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.17 per

By GlobeNewsWire
July 18, 2023

OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023

WARSAW, Ind., July 18, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused e

By Zacks Investment Research
June 29, 2023

OrthoPediatrics (KIDS) Unveils GIRO for Pediatric Orthopedics

The GIRO Growth Modulation System by OrthoPediatrics (KIDS) introduces a tether device designed specifically for pediatric patients.

By Seeking Alpha
May 2, 2023

OrthoPediatrics Corp. (KIDS) Q1 2023 Earnings Call Transcript

OrthoPediatrics Corp. (NASDAQ:KIDS ) Q1 2023 Results Conference Call May 2, 2023 8:00 AM ET Company Participants Trip Taylor - IR, Gilmartin Group Dav

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.